DaVita Inc. (BMV:DVA)

Market Cap	162.14B -42.6%
Revenue (ttm)	245.62B +6.5%
Net Income	13.44B -20.2%
EPS	177.14 -8.3%
Shares Out	n/a
PE Ratio	12.06
Forward PE	10.13
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10
Average Volume	230
Open	1,993.59
Previous Close	n/a
Day's Range	1,993.59 - 1,993.59
52-Week Range	1,993.59 - 3,113.21
Beta	n/a
RSI	70.03
Earnings Date	Feb 2, 2026

About DaVita

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 1994
• Employees: 76,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: DVA

Financial Performance

In 2025, DaVita's revenue was $13.64 billion, an increase of 6.46% compared to the previous year's $12.82 billion. Earnings were $746.80 million, a decrease of -20.24%.

Financial numbers in USD